Key result
LAAC holds a class IIb recommendation for stroke prevention in AF patients with OAC contraindications.
Why the study?
Does closure of the left atrial appendage prevent cardio-embolic stroke in patients with atrial fibrillation at high bleeding risk?
Does closure of the left atrial appendage prevent cardio-embolic stroke in patients with atrial fibrillation at high bleeding risk?
Answers are grounded in this paper and cite their sources.
LAAO is a valid option (Class IIb recommendation) for stroke prevention in AF patients with high thromboembolic risk who have contraindications to oral anticoagulants.
Closure of the left atrial appendage (LAAO) represents a valid option for the prevention of cardio-embolic stroke in patients with atrial fibrillation (AF) at high bleeding risk. Previous studies had shown that the atrial appendage represents the site of atrial thrombus formation in about 90% of cases in the presence of non-valvular AF. In all patients with AF and higher thromboembolic risk (in particular with CHA2DS2VASc score ≥2 in women and ≥1 in men) there is an indication for thromboembolic prophylaxis with AOC (oral anti-coagulants). The main guidelines and international consensus documents place the indication for the LAAO in patients with the need for thromboembolic prophylaxis who have contraindications to oral anticoagulant therapy (class of recommendation IIb).
No takes yet. Share an insight, caveat, or question.
Patti et al. (2023) conducted a review in Atrial fibrillation. Left atrial appendage closure (LAAO) was evaluated. Left atrial appendage closure is a class IIb recommendation for stroke prevention in atrial fibrillation patients with contraindications to oral anticoagulants.
Synapse has enriched 10 related papers. Consider them for comparative context: